Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kukla, Michał ^a   Adamek, Brygida ^a   Waluga, Marek ^a   Zalewska Ziob, Marzena ^a   Kasperczyk, Janusz ^a   Gabriel, Andrzej ^a   Mazur, Włodzimierz ^a   Sobala Szczygieł, Barbara ^a   Bułdak, Rafał J ^a   Zajȩcki, Wojciech ^a   Kȩpa, Lucjan ^a   Ziora, Katarzyna ^a   Zwirska Korczala, Krystyna ^a   Wiczkowski, Andrzej ^a   Hartleb, Marek ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; CHEMOKINE; CHEMOKINE LIKE RECEPTOR 1; UNCLASSIFIED DRUG; CHEMERIN PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CMKLR1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER FIBROSIS; LIVER HOMOGENATE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; BODY MASS; CASE CONTROL STUDY; CHRONIC HEPATITIS C; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

BODY MASS INDEX; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE;

EID: 84904608790     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/517820     Document Type: Article

References (53)

1. MacDougald O. A., Burant C. F., The rapidly expanding family of adipokines. Cell Metabolism 2007 6 3 159 161 10.1016/j.cmet.2007.08.010 2-s2.0-34548247242 (Pubitemid 47324145)
2. Roh S., Song S., Choi K., Katoh K., Wittamer V., Parmentier M., Sasaki S., Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 2007 362 4 1013 1018 10.1016/j.bbrc.2007.08.104 2-s2.0-34548572409 (Pubitemid 47390675)
3. Wittamer V., Franssen J., Vulcano M., Mirjolet J., Le Poul E., Migeotte I., Brézillon S., Tyldesley R., Blanpain C., Detheux M., Mantovani A., Sozzani S., Vassart G., Parmentier M., Communi D., Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 2003 198 7 977 985 10.1084/jem.20030382 2-s2.0-0141993969 (Pubitemid 37248614)
4. Rabe K., Lehrke M., Parhofer K. G., Broedl U. C., Adipokines and insulin resistance. Molecular Medicine 2008 14 11-12 741 751 10.2119/2008-00058.Rabe 2-s2.0-55749105417
5. Moretta A., Marcenaro E., Parolini S., Ferlazzo G., Moretta L., NK cells at the interface between innate and adaptive immunity. Cell Death and Differentiation 2008 15 2 226 233 10.1038/sj.cdd.4402170 2-s2.0-38049136577
6. Raucci R., Rusolo F., Sharma A., Colonna G., Castello G., Costantini S., Functional and structural features of adipokine family. Cytokine 2013 61 1 1 14 10.1016/j.cyto.2012.08.036 2-s2.0-84869861336
7. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D., Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 148 10 4687 4694 10.1210/en.2007-0175 2-s2.0-34748817386 (Pubitemid 47481514)
8. Goralski K. B., McCarthy T. C., Hanniman E. A., Zabel B. A., Butcher E. C., Parlee S. D., Muruganandan S., Sinal C. J., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 2007 282 38 28175 28188 10.1074/jbc.M700793200 2-s2.0-34948836879 (Pubitemid 47529521)
9. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F. N., Hong K. S., Kitazawa R., Iida K., Okimura Y., Kaji H., Kitazawa S., Kasuga M., Chihara K., Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 2008 582 5 573 578 10.1016/j.febslet.2008.01.023 2-s2.0-39649114784
10. Zabel B. A., Allen S. J., Kulig P., Allen J. A., Cichy J., Handel T. M., Butcher E. C., Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. The Journal of Biological Chemistry 2005 280 41 34661 34666 10.1074/jbc.M504868200 2-s2.0-27144444137 (Pubitemid 41504597)
11. Weigert J., Neumeier M., Wanninger J., Filarsky M., Bauer S., Wiest R., Farkas S., Scherer M. N., Schäffler A., Aslanidis C., Schölmerich J., Buechler C., Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology 2010 72 3 342 348 10.1111/j.1365-2265. 2009.03664.x 2-s2.0-76649090026
12. Yoshimura T., Oppenheim J. J., Chemerin reveals its chimeric nature. Journal of Experimental Medicine 2008 205 10 2187 2190 10.1084/jem.20081736 2-s2.0-53349120340
13. Meder W., Wendland M., Busmann A., Kutzleb C., Spodsberg N., John H., Richter R., Schleuder D., Meyer M., Forssmann W. G., Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Letters 2003 555 3 495 499 10.1016/S0014-5793(03)01312-7 2-s2.0-10744224272 (Pubitemid 37532599)
14. Stejskal D., Karpisek M., Hanulova Z., Svestak M., Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomedical papers of the Medical Faculty of the University Palacký Olomouc, Czechoslovakia 2008 152 2 217 221 10.5507/bp.2008.033 2-s2.0-62449203154
15. Ernst M. C., Sinal C. J., Chemerin: At the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism 2010 21 11 660 667 10.1016/j.tem.2010.08.001 2-s2.0-78049314118
16. Wanninger J., Bauer S., Eisinger K., Weiss T. S., Walter R., Hellerbrand C., Schäffler A., Higuchi A., Walsh K., Buechler C., Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver. Molecular and Cellular Endocrinology 2012 349 2 248 254 10.1016/j.mce.2011.10.032 2-s2.0-84862694192
17. Bondue B., Wittamer V., Parmentier M., Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine and Growth Factor Reviews 2011 22 5-6 331 338 10.1016/j.cytogfr.2011.11.004 2-s2.0-82955203470
18. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., Vecchi A., Franssen J., Communi D., Massardi L., Sironi M., Mantovani A., Parmentier M., Facchetti F., Sozzani S., Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. Journal of Experimental Medicine 2005 201 4 509 515 10.1084/jem.20041310 2-s2.0-20044369873 (Pubitemid 40289541)
19. Muruganandan S., Parlee S. D., Rourke J. L., Ernst M. C., Goralski K. B., Sinal C. J., Chemerin, a novel peroxisome proliferator-activated receptor γ (PPAR γ) target gene that promotes mesenchymal stem cell adipogenesis. The Journal of Biological Chemistry 2011 286 27 23982 23995 10.1074/jbc.M111.220491 2-s2.0-79959904817
20. Sell H., Laurencikiene J., Taube A., Eckardt K., Cramer A., Horrighs A., Arner P., Eckel J., Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 58 12 2731 2740 10.2337/db09-0277 2-s2.0-73249122917
21. Kaur J., Adya R., Tan B. K., Chen J., Randeva H. S., Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochemical and Biophysical Research Communications 2010 391 4 1762 1768 10.1016/j.bbrc.2009.12.150 2-s2.0-74749094447
22. Bernsmeier C., Heim M. H., Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance. Swiss Medical Weekly 2009 139 47-48 678 684 2-s2.0-73449120393
23. Lecube A., Hernández C., Simó R., Esteban J. I., Genescà J., Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. The American Journal of Gastroenterology 2007 102 10 2189 2195 10.1111/j.1572-0241.2007.01402.x 2-s2.0-34848862122 (Pubitemid 47493841)
24. Negro F., Sanyal A. J., Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver International 2009 29 supplement 2 26 37 10.1111/j.1478-3231.2008.01950.x 2-s2.0-59349094958
25. Adinolfi L. E., Gambardella M., Andreana A., Tripodi M., Utili R., Ruggiero G., Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001 33 6 1358 1364 10.1053/jhep.2001.24432 2-s2.0-0034987263 (Pubitemid 32496971)
26. Hourigan L. F., Macdonald G. A., Purdie D., Whitehall V. H., Shorthouse C., Clouston A., Powell E. E., Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999 29 4 1215 1219 10.1002/hep.510290401 2-s2.0-0032924020 (Pubitemid 29168757)
27. Kukla M., Gabriel A., Sabat D., Liszka Ł., Wilk M., Petelenz M., Musialik J., Dzindziora-Frelich I., Association between liver steatosis and angiogenesis in chronic hepatitis C. Polish Journal of Pathology 2010 61 3 154 160 2-s2.0-79953273108
28. Lonardo A., Loria P., Adinolfi L. E., Carulli N., Ruggiero G., Hepatitis C and steatosis: a reappraisal. Journal of Viral Hepatitis 2006 13 2 73 80 10.1111/j.1365-2893.2005.00669.x 2-s2.0-33645097198
29. Chen L., Liu W., Lai S., Li Y., Wang X., Zhang H., Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients. European Journal of Gastroenterology and Hepatology 2013 25 8 935 941 10.1097/MEG.0b013e32835fa988 2-s2.0-84879932831
30. Durazzo M., Belci P., Niro G., Collo A., Grisoglio E., Ambrogio V., Spandre M., Fontana R., Gambino R., Cassader M., Bo S., Variations of serum levels of adiponectin and resistin in chronic viral hepatitis. Journal of Endocrinological Investigation 2013 36 600 605
31. Kukla M., Mazur W., Bułdak R. J., Zwirska-Korczala K., Potential role of leptin, adiponectin and three novel adipokines-visfatin, chemerin and vaspin-in chronic hepatitis. Molecular Medicine 2011 17 11 1397 1410 10.2119/molmed.2010.00105 2-s2.0-82855168116
32. Kukla M., Berdowska A., Gabriel A., Sawczyn T., Mazur W., Sobala-Szczygieł B., Grzonka D., Zajecki W., Tomaszek K., Bułdak R. J., Zwirska-Korczala K., Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Polish Journal of Pathology 2011 62 4 218 228 2-s2.0-84855799544
33. Kukla M., Zwirska-Korczala K., Gabriel A., Waluga M., Warakomska I., Szczygiel B., Berdowska A., Mazur W., Wozniak-Grygiel E., Kryczka W., Chemerin, vaspin and insulin resistance in chronic hepatitis C. Journal of Viral Hepatitis 2010 17 9 661 667 10.1111/j.1365-2893.2009.01224.x 2-s2.0-77955395340
34. Scheuer P. J., The nomenclature of chronic hepatitis: time for a change. Journal of Hepatology 1995 22 1 112 114 10.1016/0168-8278(95)80269-X 2-s2.0-0028897109
35. Brunt E. M., Janney C. G., Di Bisceglie A. M., Neuschwander-Tetri B. A., Bacon B. R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology 1999 94 9 2467 2474 10.1111/j.1572-0241.1999.01377.x 2-s2.0-0033200054 (Pubitemid 29420675)
36. Kleiner D. E., Brunt E. M., van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J., Sanyal A. J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 41 6 1313 1321 10.1002/hep.20701 2-s2.0-20044374023 (Pubitemid 40770284)
37. Sell H., Divoux A., Poitou C., Basdevant A., Bouillot J., Bedossa P., Tordjman J., Eckel J., Clément K., Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. The Journal of Clinical Endocrinology & Metabolism 2010 95 6 2892 2896 10.1210/jc.2009-2374 2-s2.0-77954471976
38. Kukla M., Zwirska-Korczala K., Hartleb M., Waluga M., Chwist A., Kajor M., Ciupinska-Kajor M., Berdowska A., Wozniak-Grygiel E., Buldak R., Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2010 45 2 235 242 10.3109/00365520903443852 2-s2.0-76749098030
39. Yilmaz Y., Yonal O., Kurt R., Alahdab Y. O., Eren F., Ozdogan O., Celikel C. A., Imeryuz N., Kalayci C., Avsar E., Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2011 46 1 91 97 10.3109/00365521.2010. 516452 2-s2.0-78651368690
40. Ernst M. C., Issa M., Goralski K. B., Sinal C. J., Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010 151 5 1998 2007 10.1210/en.2009-1098 2-s2.0-77953156149
41. Döcke S., Lock J. F., Birkenfeld A. L., Hoppe S., Lieske S., Rieger A., Raschzok N., Sauer IM., Florian S., Osterhoff MA., Heller R., Herrmann K., Lindenmüller S., Horn P., Bauer M., Weickert M. O., Neuhaus P., Stockmann M., Mhlig M., Pfeiffer A. F., Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology 2013 169 547 557
42. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M., Teng M., Duvic M., Chandraratna R. A. S., Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. Journal of Investigative Dermatology 1997 109 1 91 95 10.1111/1523-1747.ep12276660 2-s2.0-0030847171 (Pubitemid 27305655)
43. Kukla M., Warakomska I., Gabriel A., Zwirska-Korczala K., Rybus-Kalinowska B., Berdowska A., Kalinowski M., Chwist A., Waluga M., Kuka D., Kpa L., Serum levels of sICAM-1, TNF α sTNF-R1, and sTNF-R2 in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. Experimental & Clinical Hepatology 2008 4 1 12 20 2-s2.0-70449588196
44. Krautbauer S., Wanninger J., Eisinger K., Hader Y., Beck M., Kopp A., Schmid A., Weiss T. S., Dorn C., Buechler C., Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Experimental and Molecular Pathology 2013 95 2 199 205 10.1016/j.yexmp.2013.07.009 2-s2.0-84882741140
45. Ernst M. C., Haidl I. D., Zuńĩga L. A., Dranse H. J., Rourke J. L., Zabel B. A., Butcher E. C., Sinal C. J., Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012 153 2 672 682 10.1210/en.2011-1490 2-s2.0-84856107177
46. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F. N., Hong K. S., Kitazawa R., Iida K., Okimura Y., Kaji H., Kitazawa S., Kasuga M., Chihara K., Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 2008 582 5 573 578 10.1016/j.febslet.2008.01.023
47. Cash J. L., Hart R., Russ A., Dixon J. P., Colledge W. H., Doran J., Hendrick A. G., Carlton M. B., Synthetic chemerin-derived peptides suppress inflammation through ChemR23. Journal of Experimental Medicine 2008 205 767 775 (Pubitemid 351549876)
48. Caldwell S., Ikura Y., Dias D., Isomoto K., Yabu A., Moskaluk C., Pramoonjago P., Simmons W., Scruggs H., Rosenbaum N., Wilkinson T., Toms P., Argo C. K., Al-Osaimi A. M. S., Redick J. A., Hepatocellular ballooning in NASH. Journal of Hepatology 2010 53 4 719 723 10.1016/j.jhep.2010.04.031 2-s2.0-77956269092
49. Döcke S., Lock J. F., Birkenfeld A. L., Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology 2013 169 5 547 557 10.1530/EJE-13-0112
50. Tan B. K., Chen J., Farhatullah S., Adya R., Kaur J., Heutling D., Lewandowski K. C., O'Hare J. P., Lehnert H., Randeva H. S., Insulin and adipose tissue chemerin. Diabetes 2009 58 1971 1977
51. Bauer S., Bala M., Kopp A., Eisinger K., Schmid A., Schneider S., Neumeier M., Buechler C., Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo. European Journal of Clinical Investigation 2012 42 1213 1220
52. Alfadda A. A., Sallam R. M., Chishti M. A., Moustafa A. S., Fatma S., Alomaim W. S., Al-Naami M. Y., Bassas A. F., Chrousos G. P., Jo H., Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: Adipose depot specificity and gender dimorphism. Molecules and Cells 2012 33 6 591 596 10.1007/s10059-012-0012-7 2-s2.0-84863479504
53. Martínez-García M. A., Montes-Nieto R., Fernández-Durán E., Insenser M., Luque-Ramírez M., Escobar-Morreale H. F., Escobar-Morreale HF: Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). Journal of Clinical Endocrinology & Metabolism 2013 98 E388 E396